FDA status
Wegovy and compounded semaglutide are not the same regulatory product
Both conversations involve semaglutide, but the regulatory status is different. Wegovy has FDA-reviewed prescribing information for specific labeled uses. A compounded semaglutide prescription is prepared by a pharmacy for an individual patient and should not be described as an FDA-approved finished drug or a generic Wegovy pen.
- Ask which exact semaglutide product is being discussed, why it fits your diagnosis or goal, and whether a branded or compounded path is being considered.
- Compounded medications require clinician oversight, pharmacy transparency, patient-specific labeling, storage instructions, and follow-up plans.
- FDA has warned about risks with unapproved GLP-1 products, dosing errors, salt-form confusion, and products sold outside legitimate prescription channels.